SERPINB3 modulates TGF-Β expression in chronic liver disease

Laboratory Investigation

Volumn 90, Issue 7, 2010, Pages 1016-1023

  Turato, Cristian ^a   Calabrese, Fiorella ^b   Biasiolo, Alessandra ^b   Quarta, Santina ^b   Ruvoletto, Mariagrazia ^b   Tono, Natascia ^a   Paccagnella, Daniela ^c   Fassina, Giorgio ^d   Merkel, Carlo ^b   Harrison, Tim J ^e   Gatta, Angelo ^b   Pontisso, Patrizia ^b  

^a VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c S ANTONIO HOSPITAL   (Italy)

^d Xeptagen SpA   (Italy)

^e ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

cirrhosis; cytokines; liver fibrosis; SERPINB3 reactive site loop

Indexed keywords

MESSENGER RNA; SERINE PROTEINASE INHIBITOR; SERPINB3; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; SQUAMOUS CELL CARCINOMA RELATED ANTIGEN; SQUAMOUS CELL CARCINOMA-RELATED ANTIGEN; TRANSFORMING GROWTH FACTOR BETA1; TUMOR ANTIGEN;

ARTICLE; CELL STRAIN HEPG2; CELL STRAIN HUH7; CHRONIC LIVER DISEASE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPRESSION VECTOR; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; LIVER BIOPSY; LIVER CELL CULTURE; LIVER FIBROSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; ADULT; AGED; ENZYME ACTIVE SITE; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; LIVER; LIVER CIRRHOSIS; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; TUMOR CELL LINE;

ADULT; AGED; ANTIGENS, NEOPLASM; CATALYTIC DOMAIN; CELL LINE, TUMOR; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION; HUMANS; LIVER; LIVER CIRRHOSIS; MALE; MIDDLE AGED; SERPINS; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA1;

EID: 77954155454     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2010.55     Document Type: Article

References (42)

1. Friedman SL. Liver fibrosis from bench to bedside. J Hepatol 2003;38:38-53.
2. Bataller R, Brenner DA. Liver fibrosis. J Clin Invest 2005;115:209-218.
3. Bruix J, Llovet JM. Hepatitis B virus and hepatocellular carcinoma. J Hepatol 2003;39:S59-S63.
4. Benvegnù L, Gios M, Boccato S, et al. Natural history of compensated viral cirrhosis: a prospective study on the incidence and hierarchy of major complications. Gut 2004;53:744-749.
5. Pinzani M, Rombouts K. Liver fibrosis: from the bench to clinical targets. Dig Liver Dis 2004;36:231-242.
6. Bissell DM, Roulot D, George J. Transforming growth factor beta and the liver. Hepatology 2001;34:859-867.
7. Moustakas A, Heldin CH. Non-Smad TGF-beta signals. J Cell Sci 2005;118:3573-3584.
8. Zhang Y, Feng XH, Derynck R. Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-beta-induced transcription. Nature 1998;394:909-913.
9. Liberati NT, Datto MB, Frederick JP, et al. Smads bind directly to the Jun family of AP-1 transcription factors. Proc Natl Acad Sci USA 1999;96:4844-4849.
10. Miyazono K, Hellman U, Wernstedt C, et al. Latent high molecular weight complex of transforming growth factor beta 1. Purification from human platelets and structural characterization. J Biol Chem 1988;263:6407-6415.
11. Knittel T, Janneck T, Müller L, et al. Transforming growth factor beta 1-regulated gene expression of Ito cells. Hepatology 1996;24:352-360.
12. Nelson DR, Gonzalez-Peralta RP, Qian K, et al. Transforming growth factor-beta 1 in chronic hepatitis C. J Viral Hepat 1997;4:29-35.
13. Dudás J, Kovalszky I, Gallai M, et al. Expression of decorin, transforming growth factor-beta 1, tissue inhibitor metalloproteinase 1 and 2, and type IV collagenases in chronic hepatitis. Am J Clin Pathol 2001;115:725-735.
14. Calabrese F, Valente M, Giacometti C, et al. Parenchymal transforming growth factor beta-1: its type II receptor and Smad signaling pathway correlate with inflammation and fibrosis in chronic liver disease of viral etiology. J Gastroenterol Hepatol 2003;18:1302-1308.
15. Nitta T, Kim JS, Mohuczy D, et al. Murine cirrhosis induces hepatocyte epithelial mesenchymal transition and alterations in survival signaling pathways. Hepatology 2008;48:909-919.
16. Dooley S, Hamzavi J, Ciuclan L, et al. Hepatocyte-specific Smad7 expression attenuates TGF-beta-mediated fibrogenesis and protects against liver damage. Gastroenterology 2008;135:642-659.
17. Calabrese F, Lunardi F, Giacometti C, et al. Overexpression of squamous cell carcinoma antigen in idiopathic pulmonary fibrosis: clinicopathological correlations. Thorax 2008;63:795-802.
18. Selman M, King TE, Pardo A. Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med 2001;134:136-151. Review.
19. Gettins PG. Serpin structure, mechanism, and function. Chem Rev 2002;102:4751-4804. Review.
20. Kato H. Expression and function of squamous cell carcinoma antigen. Anticancer Res 1996;16:2149-2153. (Pubitemid 26265557)
21. Pontisso P, Calabrese F, Benvegnù L, et al. Overexpression of squamous cell carcinoma antigen variants in hepatocellular carcinoma. Br J Cancer 2004;90:833-837.
22. Giannelli G, Marinosci F, Sgarra C, et al. Clinical role of tissue and serum levels of SCCA antigen in hepatocellular carcinoma. Int J Cancer 2005;116:579-583.
23. Giannelli G, Fransvea E, Trerotoli P, et al. Clinical validation of combined serological biomarkers for improved hepatocellular carcinoma diagnosis in 961 patients. Clin Chim Acta 2007;383:147-152.
24. Beneduce L, Castaldi F, Marino M, et al. Squamous cell carcinoma antigen-immunoglobulin M complexes as novel biomarkers for hepatocellular carcinoma. Cancer 2005;103:2558-2565.
25. Biasiolo A, Chemello L, Quarta S, et al. Monitoring SCCA-IgM complexes in serum predicts liver disease progression in patients with chronic hepatitis. J Viral Hepat 2008;15:246-249.
26. Guido M, Roskams T, Pontisso P, et al. Squamous cell carcinoma antigen in human liver carcinogenesis. J Clin Pathol 2008;61: 445-447.
27. Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995;22:696-699.
28. Moore PL, Ong S, Harrison TJ. Squamous cell carcinoma antigen 1-mediated binding of hepatitis B virus to hepatocytes does not involve the hepatic serpin clearance system. J Biol Chem 2003;278:46709-46717.
29. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001;25:402-408.
30. Beghe B, Bazzan E, Baraldo S, et al. Transforming growth factor-beta type II receptor in pulmonary arteries of patients with very severe COPD. Eur Respir J 2006;28:556-562.
31. Friedman SL. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem 2000;275:2247-2250. Review.
32. Gressner AM. Mediators of hepatic fibrogenesis. Hepato-Gastroenterol 1996;43:92-103.
33. Ogawa K, Chen F, Kuang C, et al. Suppression of matrix metalloproteinase-9 transcription by transforming growth factor-beta is mediated by a nuclear factor-kappaB site. Biochem J 2004;381: 413-422.
34. Verrecchia F, Chu ML, Mauviel A. Identification of novel TGF-beta/Smad gene targets in dermal fibroblasts using a combined cDNA microarray/promoter transactivation approach. J Biol Chem 2001;276:17058-17062.
35. Liotta LA, Stetler-Stevenson WG. Tumor invasion and metastasis: an imbalance of positive and negative regulation. Cancer Res 1991;51:5054-5059. Review.
36. He Y, Liu XD, Chen ZY, et al. Interaction between cancer cells and stromal fibroblasts is required for activation of the uPAR-uPA-MMP-2 cascade in pancreatic cancer metastasis. Clin Cancer Res 2007;13:3115-3124.
37. Suminami Y, Nagashima S, Vujanovic NL, et al. Inhibition of apoptosis in human tumor cells by tumor-associated serpin, SCC antigen. Br J Cancer 2000;82:981-989.
38. Takeda A, Kajiya A, Iwasawa A, et al. Aberrant expression of serpin squamous cell carcinoma antigen 2 in human tumor tissues and cell lines: evidence of protection from tumor necrosis factor-mediated apoptosis. Biol Chem 2002;383:1231-1236.
39. Nguyen LN, Furuya MH, Wolfraim LA, et al. Transforming growth factor-beta differentially regulates oval cell and hepatocyte proliferation. Hepatology 2007;45:31-41.
40. Xu J, Lamouilee S, Derynck R. TGF-b-induced epithelial to mesenchymal transition. Cell Res 2009;19:156-172.
41. Quarta S, Turato C, Ruvoletto MG, et al. SERPINB3 induces epithelial mesenchymal transition. Hepatology 2009;50(Suppl):379A.
42. Schechter I, Berger A. On the size of the active site in proteases. I. Papain. Biochem Biophys Res Commun 1967;27:157-162.